SI20851B - Mezoprogestini (modulatorji receptorja progesterona) kot komponenta pripravkov za nadomestno zdravljenje s hormoni (NZH) - Google Patents
Mezoprogestini (modulatorji receptorja progesterona) kot komponenta pripravkov za nadomestno zdravljenje s hormoni (NZH) Download PDFInfo
- Publication number
- SI20851B SI20851B SI200020041A SI200020041A SI20851B SI 20851 B SI20851 B SI 20851B SI 200020041 A SI200020041 A SI 200020041A SI 200020041 A SI200020041 A SI 200020041A SI 20851 B SI20851 B SI 20851B
- Authority
- SI
- Slovenia
- Prior art keywords
- mesoprogestins
- hrt
- replacement therapy
- component
- hormone replacement
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Ta izum se nanaša na uporabo mozoprogestinov kot farmacevtskih komponent za izdelavo zdravila za nadomestno zdravljenje s hormoni (NZH) in kot komponenta za kombinirano uporabo skupaj z estrogenom za izdelavo zdravila za NZH in v ustreznih metodah NZH in metodah za zdravljenje pomanjkanja hormonov in simptomov hormonske nepravilnosti. Mezoprogestini so definirani kot spojine, ki imajo tako agonistične kot antagonistične aktivnosti na receptorju progesterona (PR) in vivo. Stabilizirajo funkcijo PR na vmesni stopnji med agonistom in antagonistom. Ustreznih funkcijskih stanj ni mogoče doseči s progestini ali antiprogrestini. J867, J912, J956 in J1042 so prednostni mezoprogestini v smislu tega izuma.
Description
Mezoprogestini (modulatorji receptorja progesterona) kot komponenta pripravkov za nadomestno zdravljenje s hormoni (NZH)
Claims (6)
1. Uporaba mezoprogestinov, izbranih iz skupine, ki jo sestavljajo [4-[17P-metoksi-17a(metoksimetil)-3-oksoestra-4,9-dien-11p-il]benzaldehid-(1E)-oksimj (J867), [4-[17p(3-hidroksi17a-(metoksimetil)-3-oksoestra-4,9-dien-1ip-il]benzaldehid-(1E)-oksim] (J912) in [4-[17βmetoksi-17a-(metoksimetil)-3-oksoestra-4,9-dien-11 β-il] benzaldehid-( 1 E)-[O(etilamino)karbonil]oksim] (J956) kot farmacevtske sestavine za izdelavo zdravila za nadomestno zdravljenje s hormoni (NZH).
2. Uporaba mezoprogestina po zahtevku 1 skupaj z estrogenom za izdelavo zdravila za NZH.
3. Uporaba mezoprogestina po zahtevkih 1 ali 2 v dnevnem odmerku od 1,0 do 50,0 mg.
4. Uporaba po zahtevku 3, pri čemer je dnevni odmerek mezoprogestina 5,0 do 25,0 mg.
5. Uporaba po zahtevku 4, pri čemer je dnevni odmerek 10,0 do 25,0.
6. Uporaba po zahtevku 2, pri čemer je estrogen etinilestradiol, estradiol, estradiol ester ali 3sulfamat 17β-etinilestradiola ali 17p-estradiola.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38614099A | 1999-08-31 | 1999-08-31 | |
PCT/US2000/023771 WO2001034126A2 (en) | 1999-08-31 | 2000-08-31 | Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt) |
Publications (2)
Publication Number | Publication Date |
---|---|
SI20851A SI20851A (sl) | 2002-10-31 |
SI20851B true SI20851B (sl) | 2009-06-30 |
Family
ID=23524333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200020041A SI20851B (sl) | 1999-08-31 | 2000-08-31 | Mezoprogestini (modulatorji receptorja progesterona) kot komponenta pripravkov za nadomestno zdravljenje s hormoni (NZH) |
Country Status (33)
Country | Link |
---|---|
EP (1) | EP1605924B1 (sl) |
JP (1) | JP2003513908A (sl) |
KR (1) | KR100729311B1 (sl) |
CN (1) | CN1454088A (sl) |
AR (1) | AR025456A1 (sl) |
AT (1) | ATE413168T1 (sl) |
AU (1) | AU781836B2 (sl) |
BG (1) | BG65846B1 (sl) |
BR (1) | BR0013710A (sl) |
CA (1) | CA2383659C (sl) |
CO (1) | CO5200773A1 (sl) |
CZ (1) | CZ301412B6 (sl) |
DE (1) | DE60040764D1 (sl) |
EA (1) | EA007840B1 (sl) |
EE (1) | EE200200102A (sl) |
ES (1) | ES2316402T3 (sl) |
HR (1) | HRP20020266A2 (sl) |
HU (1) | HUP0202460A3 (sl) |
IL (2) | IL148417A0 (sl) |
LT (1) | LT5011B (sl) |
LV (1) | LV12942B (sl) |
MX (1) | MXPA02002190A (sl) |
NO (1) | NO20021000L (sl) |
NZ (1) | NZ517469A (sl) |
PE (1) | PE20010581A1 (sl) |
PL (1) | PL198798B1 (sl) |
RO (1) | RO122180B1 (sl) |
RS (1) | RS50396B (sl) |
SI (1) | SI20851B (sl) |
SK (1) | SK287121B6 (sl) |
UA (1) | UA75339C2 (sl) |
WO (1) | WO2001034126A2 (sl) |
ZA (1) | ZA200201621B (sl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1525215B1 (de) * | 2002-08-02 | 2006-09-06 | Schering Aktiengesellschaft | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie |
DE10236405A1 (de) | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
US20040097591A1 (en) * | 2002-11-18 | 2004-05-20 | Kristof Chwalisz | Use of selective progesterone receptor modulators for the treatment of androgen deficiency |
RU2611370C1 (ru) * | 2016-01-12 | 2017-02-21 | Общество с ограниченной ответственностью Медицинская Корпорация "РАНА" | Применение препарата Лаеннек для уменьшения или устранения проявления менопаузальных симптомов (варианты) |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2054271A (en) | 1932-05-17 | 1936-09-15 | Schering Kahlbaum Ag | Production of crystallized hormone esters |
DE699310C (de) | 1936-11-20 | 1940-11-27 | Chemische Ind Ges | Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols |
US2225419A (en) | 1937-03-01 | 1940-12-17 | Schering Corp | Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols |
US2611773A (en) | 1951-08-21 | 1952-09-23 | Upjohn Co | Estradiol 17-cyclopenetanepropionate |
US2990414A (en) | 1957-03-26 | 1961-06-27 | Syntex Sa | 17-undecenoate of estradiol |
US4729999A (en) * | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
MX9301121A (es) * | 1992-03-02 | 1993-09-01 | Schering Ag | Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina. |
TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
DE4225623C2 (de) * | 1992-08-03 | 1994-06-30 | Karl Hehl | Verfahren zur Herstellung einer pulverförmigen Spritzgußmasse für die Herstellung von Porzellan und deren Verwendung |
US5468736A (en) * | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
DE4332284C2 (de) * | 1993-09-20 | 1997-05-28 | Jenapharm Gmbh | 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE4332283A1 (de) * | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US5391557A (en) * | 1993-10-15 | 1995-02-21 | Eli Lilly And Company | Methods for the treatment of peri-menopausal syndrome |
JPH10507461A (ja) * | 1994-10-24 | 1998-07-21 | シエーリング アクチエンゲゼルシヤフト | 必要に応じて女性の稔性を調節するための競合的プロゲステロン拮抗物質 |
DE19610635A1 (de) * | 1996-03-11 | 1997-09-18 | Schering Ag | Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie |
AU725670B2 (en) * | 1996-06-25 | 2000-10-19 | Akzo Nobel N.V. | Progestogen-anti-progestogen regimens |
WO1998005679A2 (en) * | 1996-08-05 | 1998-02-12 | Duke University | Mixed agonists of the progesterone receptor and assays therefor |
DE19809845A1 (de) * | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
SK10032001A3 (sk) * | 1999-01-14 | 2002-05-09 | Bayer Corporation | Substituované 2-aryliminoheterocykly a prostriedky s ich obsahom na použitie ako činidlo viažuce receptor progesterónu |
-
2000
- 2000-08-31 HU HU0202460A patent/HUP0202460A3/hu unknown
- 2000-08-31 KR KR1020027002815A patent/KR100729311B1/ko not_active IP Right Cessation
- 2000-08-31 PE PE2000000892A patent/PE20010581A1/es not_active Application Discontinuation
- 2000-08-31 CA CA002383659A patent/CA2383659C/en not_active Expired - Lifetime
- 2000-08-31 CN CN00812257A patent/CN1454088A/zh active Pending
- 2000-08-31 CZ CZ20020706A patent/CZ301412B6/cs not_active IP Right Cessation
- 2000-08-31 NZ NZ517469A patent/NZ517469A/en unknown
- 2000-08-31 ES ES00991840T patent/ES2316402T3/es not_active Expired - Lifetime
- 2000-08-31 EP EP00991840A patent/EP1605924B1/en not_active Expired - Lifetime
- 2000-08-31 JP JP2001536126A patent/JP2003513908A/ja active Pending
- 2000-08-31 SI SI200020041A patent/SI20851B/sl not_active IP Right Cessation
- 2000-08-31 DE DE60040764T patent/DE60040764D1/de not_active Expired - Lifetime
- 2000-08-31 AR ARP000104537A patent/AR025456A1/es unknown
- 2000-08-31 SK SK297-2002A patent/SK287121B6/sk not_active IP Right Cessation
- 2000-08-31 RO ROA200200230A patent/RO122180B1/ro unknown
- 2000-08-31 RS YUP-141/02A patent/RS50396B/sr unknown
- 2000-08-31 AU AU36332/01A patent/AU781836B2/en not_active Ceased
- 2000-08-31 EA EA200200285A patent/EA007840B1/ru not_active IP Right Cessation
- 2000-08-31 BR BR0013710-3A patent/BR0013710A/pt not_active Application Discontinuation
- 2000-08-31 EE EEP200200102A patent/EE200200102A/xx unknown
- 2000-08-31 PL PL353931A patent/PL198798B1/pl not_active IP Right Cessation
- 2000-08-31 IL IL14841700A patent/IL148417A0/xx unknown
- 2000-08-31 CO CO00065516A patent/CO5200773A1/es not_active Application Discontinuation
- 2000-08-31 UA UA2002032428A patent/UA75339C2/uk unknown
- 2000-08-31 WO PCT/US2000/023771 patent/WO2001034126A2/en active IP Right Grant
- 2000-08-31 AT AT00991840T patent/ATE413168T1/de not_active IP Right Cessation
-
2002
- 2002-02-26 BG BG106443A patent/BG65846B1/bg unknown
- 2002-02-26 ZA ZA200201621A patent/ZA200201621B/en unknown
- 2002-02-27 IL IL148417A patent/IL148417A/en not_active IP Right Cessation
- 2002-02-28 NO NO20021000A patent/NO20021000L/no not_active Application Discontinuation
- 2002-02-28 MX MXPA02002190A patent/MXPA02002190A/es active IP Right Grant
- 2002-03-27 LT LT2002037A patent/LT5011B/lt not_active IP Right Cessation
- 2002-03-28 LV LVP-02-54A patent/LV12942B/en unknown
- 2002-03-28 HR HR20020266A patent/HRP20020266A2/hr not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9709934A (pt) | Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga | |
HRP20070188B1 (hr) | Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva | |
ME00292B (me) | Drospirenon za terapiju zamjene hormona | |
CA2281844A1 (en) | Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use | |
RS50972B (sr) | Farmaceutski sastav koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate | |
WO2006135638A3 (en) | Tanaproget compositions containing ethinyl estradiol | |
AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
AR011480A1 (es) | ACIL-ANILIDAS SUSTITUIDAS CON RADICALES (HETERO) CICLICOS, NO ESTEROIDALES, CON ACTIVIDAD GESTÁGENA Y ANDRoGENA MIXTA. | |
UA37259C2 (uk) | Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч | |
TW200514560A (en) | Pharmaceutical formulation for contraception and hormone-replacement therapy | |
CO5261567A1 (es) | Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas | |
BR0114665A (pt) | Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio | |
TR199900764T2 (xx) | Bir �strojen bile�i�i ve progestasyonel bir bile�ikten olu�an hormonal bir terkip. | |
SI20851B (sl) | Mezoprogestini (modulatorji receptorja progesterona) kot komponenta pripravkov za nadomestno zdravljenje s hormoni (NZH) | |
LT2002035A (lt) | Mezoprogestinai (progesterono receptoriaus moduliatoriai) kaip moterų kontraceptikų komponentas | |
HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
EA200601089A1 (ru) | Трансдермальная доставка гормонов без необходимости использования агентов, усиливающих проникновение | |
ATE395047T1 (de) | Feste perorale arzneiform zur kontrazeption, die dienogest und ethinylestradiol enthält | |
EA200501739A1 (ru) | Композиция, содержащая антагонисты рецептора прогестерона и чистые антиэстрогены, предназначенные для профилактики и лечения гормонзависимых заболеваний | |
SI20852B (sl) | Mezoprogestini (modulatorji receptorja progesterona) za zdravljenje in preprečevanje benignih hormonsko povzročenih ginekoloških motenj | |
DK1652526T3 (da) | Anvendelse af (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-on i behandling af svær depressionslidelse | |
MX2007009061A (es) | Preparacion farmaceutica para la anticoncepcion oral. | |
WO1999045886A3 (en) | New contraceptive kit for monotherapy | |
HRP20070360A2 (en) | Pharmaceutical compositions comprising drospirenone | |
IL125983A0 (en) | Pharmaceutical composition comprising factor xiiia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SP73 | Change of data on owner |
Owner name: SCHERING AKTIENGESELLSCHAFT; DE Effective date: 20041118 |
|
IF | Valid on the event date | ||
OU02 | Decision according to article 73(2) ipa 1992, publication of decision on partial fulfilment of the invention and change of patent claims |
Effective date: 20090422 |
|
SP73 | Change of data on owner |
Owner name: BAYER SCHERING PHARMA AG; DE Effective date: 20090325 |
|
KO00 | Lapse of patent |
Effective date: 20110413 |